By Tony Fong
NEW YORK (GenomeWeb News) – Molecular diagnostics firm T2 Biosystems is set to begin a clinical trial for its first assay targeting Candida fungal infections as it prepares to seek regulatory approval in the US next year.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.
A technology that has the potential to make species go extinct could be used against the Zika virus.
University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.
If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?
This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.